KALA BIO Inc.
Last updated September 27, 2026
Organization details
- Legal name
- KALA BIO Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- KALA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001479419
Board of directors
-
Andrew I. Koven · DirectorSince 2023
-
C. Daniel Myers · DirectorSince 2023
-
Gregory D. Perry · DirectorSince 2023
-
Howard B. Rosen · DirectorSince 2023
-
Marjan Farid · DirectorSince 2023
-
Mark S. Blumenkranz · DirectorSince 2023
-
Mark T. Iwicki · Director · CHIEF EXECUTIVE OFFICERSince 2023
Chief executives
Mark T. Iwicki
· CHIEF EXECUTIVE OFFICER
Dates unknown
Board connections
3 of this board's directors also sit on 4 other boards.
- via Mark T. Iwicki
- via Andrew I. Koven
- via Mark T. Iwicki
- via Howard B. Rosen
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 30, 2024 | Felix Baker 10% owner | Open-market purchase | +30,620 | $6.44 | $197,193 |
| Dec 30, 2024 | Felix Baker 10% owner | Open-market purchase | +279,939 | $6.44 | $1,802,807 |
| Jun 26, 2024 | Todd Bazemore Officer (SEE REMARKS) | Open-market sale | −4,653 | $4.75 | $22,102 |
| Jun 26, 2024 | Kharabi Darius Officer (CHIEF BUSINESS OFFICER) | Open-market sale | −5,158 | $4.75 | $24,501 |
| Jun 26, 2024 | Reumuth Mary Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | −4,163 | $4.75 | $19,774 |
| Jun 26, 2024 | Mark T. Iwicki Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −15,168 | $4.75 | $72,048 |
| Jun 26, 2024 | Brazzell Romulus K Officer (SEE REMARKS) | Open-market sale | −5,489 | $4.75 | $26,073 |
| Jun 11, 2024 | Howard B. Rosen Director | Grant or award | +1,400 | — | — |
| Jun 11, 2024 | Marjan Farid Director | Grant or award | +1,400 | — | — |
| Jun 11, 2024 | Gregory D. Perry Director | Grant or award | +1,400 | — | — |
| Jun 11, 2024 | C. Daniel Myers Director | Grant or award | +1,400 | — | — |
| Jun 11, 2024 | Andrew I. Koven Director | Grant or award | +1,750 | — | — |
| Jun 11, 2024 | Mark S. Blumenkranz Director | Grant or award | +1,400 | — | — |
| May 31, 2024 | Todd Bazemore Officer (SEE REMARKS) | Open-market sale | −2,093 | $6.09 | $12,746 |
| May 31, 2024 | Kharabi Darius Officer (CHIEF BUSINESS OFFICER) | Open-market sale | −231 | $6.09 | $1,407 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.